No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $80
BofA Securities Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $80
BofA Adjusts Price Target on Ultragenyx Pharmaceutical to $80 From $83, Keeps Buy Rating
Ukrainian Minister Announces 'Significant Progress' in Minerals Deal Talks With US
Wedbush Maintains Ultragenyx Pharmaceutical(RARE.US) With Hold Rating, Cuts Target Price to $39
Sector Update: Health Care